OxyContin Revolving-Door Outrage
8:42–9:10 · 28s
Makary and Kelly detail how FDA reviewer Curtis Wright approved OxyContin’s ‘non-addictive’ label, then immediately joined Purdue Pharma, exemplifying captured regulation.


8:42–9:10 · 28s
Makary and Kelly detail how FDA reviewer Curtis Wright approved OxyContin’s ‘non-addictive’ label, then immediately joined Purdue Pharma, exemplifying captured regulation.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.